AFP and cancer: Furthermore, the combination of mSEPT9 and other biomarkers (such as AFP) has been emphasized in recent research, not only to increase sensitivity for malignant tumor diagnosis but also to predict overall survival, microvascular invasion, and tumor proliferation (26).